<DOC>
	<DOCNO>NCT01209403</DOCNO>
	<brief_summary>The purpose study investigate whether anabolic potential insulin may use reverse catabolic effect hemodialysis non-diabetic patient end-stage renal failure .</brief_summary>
	<brief_title>Insulin-like Growth Factor ( IGF-I ) Hemodialysis Patients</brief_title>
	<detailed_description>Nutritional marker lean body mass serum albumin strong predictor mortality morbidity patient end-stage renal failure ( ESRF ) maintenance hemodialysis ( HD ) . Maintenance HD consider contribute malnutrition patient ESRF , exact mechanism remain unknown . However , recently show bioactivity insulin-like growth factor-I ( IGF-I ) reduce 50 % HD . Furthermore , show reduction bioactivity IGF-I directly link up-regulation IGF-binding protein-1 ( IGFBP-1 ) , acutely regulate IGFBP , increase 6-fold HD . IGFBP-1 produce liver , primarily control insulin , promptly inhibit hepatic production IGFBP-1 . As plasma insulin remain fairly low maintenance HD , increase IGFBP-1 may explain absence insulin . The finding HD acutely down-regulates bioactivity IGF-I up-regulation IGFBP-1 may explain catabolic mechanism HD per se , also open new treatment strategy ESRF patient undergo maintenance HD . Thus , basis previous study hypothesize treatment ERSF patient high dos insulin maintenance HD may counter-act HD-induced stimulation IGFBP-1 , make possible preserve bioactivity IGF-I , thereby abolish catabolic impact HD .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>&gt; 18 year stable patient maintenance hemodialysis &gt; 3 month wellfunctioning arteriovenous ( AV ) shunt recirculation &lt; 5 % informed consent diabetes mellitus body mass index &lt; 18.5 kg/m2 &gt; 30 kg/m2 malnutrition ( subjective global assessment ( SGA ) score C ) malignancy use immunosuppressive drug include glucocorticosteroids severe infectious disease &lt; 4 week pregnancy Exclusion Criteria study : myocardial infarction arrythmia hemodynamic derangement permanent thrombosis arteriovenous ( AV ) shunt severe infectious disease renal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Dialysis</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Insulin-Like Growth Factor I</keyword>
	<keyword>Insulin-Like Growth Factor Binding Protein 1</keyword>
	<keyword>Inflammation</keyword>
</DOC>